NVAX Price Prediction Next Week
Analysis and Insights
To predict the stock price of Novavax (NVAX) for the next trading week, we analyze both news sentiment and technical indicators.
News Sentiment Analysis:
FDA Meeting Cancellation: The FDA canceled a meeting related to flu vaccine discussions, raising concerns about transparency and potential influence from vaccine skeptics. This could impact NVAX's regulatory environment.
CDC Study on Vaccines and Autism: The CDC plans to study potential links between vaccines and autism, despite previous studies debunking such connections. This could affect public sentiment and regulatory scrutiny.
Novavax's Financial Performance: NVAX reported Q4 revenue of $88.31 million, above expectations but down 69.68% year-over-year. The company is shifting focus to pipeline expansion and partnerships, including a $1.2 billion agreement with Sanofi.
Technical Analysis:
- Current Price: $8.325 (as of 2025-03-07).
- RSI: 63.86 (6-period), 54.82 (12-period), 53.43 (14-period), indicating the stock is not in overbought or oversold territory.
- MACD: -0.16 (12-period), showing a bearish signal, but with a rising Stochastic Oscillator (62.94), suggesting potential bullish momentum.
- Fibonacci Levels:
- Pivot: $7.78
- Resistance Levels: $8.40, $8.78
- Support Levels: $7.17, $6.79
Price Prediction:
Given the mixed news sentiment and technical indicators, NVAX is likely to test the first resistance level at $8.40 next week. If it breaks above this level, the next target could be $8.78. However, if it fails to breach $8.40, the stock may decline to $7.17.
Recommendation:
Buy NVAX with a target price of $8.40 and a stop-loss at $7.17. The stock is expected to reach $8.40 by the end of the next trading week.
NVAX Similar Chart Price Prediction
The price of NVAX is predicted to go up 0.7%, based on the high correlation periods with DDS. The similarity of these two price pattern on the periods is 95.63%.
NVAX
DDS
Up: 0.7%Similarity: 95.63%
NVAX Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030
Year
NVAX Price Forecast($)
Potential Return(%)
2025
15.000
61.030
2026
19.000
128.090
2027
15.000
80.070
2028
15.000
80.070
2029
25.000
200.120
2030
20.000
140.100
What is NVAX stock price prediction 2025 ?
What is NVAX stock price prediction 2026 ?
What is NVAX stock price prediction 2027 ?
What is NVAX stock price prediction 2028 ?
What is NVAX stock price prediction 2029 ?
What is NVAX stock price prediction 2030 ?
NVAX Revenue Forecast
NVAX EPS Forecast
NVAX FAQs
What is NVAX revenue forecast for next quarter？
What is NVAX eps forecast for next quarter？
NVAX Analyst's Forecast
Roger Song
Jefferies
Strong Buy
2024-10-16
Price Target
$31 → $25
Upside
+146.31%
Jefferies lowered the firm's price target on Novavax to $25 from $31 and keeps a Buy rating on the shares after the company announced that the FDA has placed a clinical hold on the Investigational New Drug, or IND, application for its COVID-19-Influenza Combination, or CIC, and stand-alone influenza vaccine candidates. The clinical hold on the CIC candidate due to a serious adverse event, or SAE, seen in Phase 2 study was "a surprise given quite clean safety history," says the analyst, who believes the hold could be resolved into Phase 3 with significant upside if a trial is eventually successful, but also sees uncertainty on the timeline and increased risk.
Mayank Mamtani
B. Riley Securities
Strong Buy
2024-10-10
Price Target
$23 → $26
Upside
+101.47%
